{"document_type": "article", "byline": [], "news_desk": "Letters", "slideshow_credits": null, "abstract": null, "multimedia": [], "headline": {"kicker": "Letters", "content_kicker": "Letters", "print_headline": "For Some Diabetics, a Struggle to Pay for Insulin", "main": "For Some Diabetics, a Struggle to Pay for Insulin"}, "print_page": "24", "keywords": [{"value": "Diabetes", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Insulin", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Eli Lilly and Company", "is_major": "N", "rank": "4", "name": "organizations"}], "snippet": "The drug company Eli Lilly and an organization that helps diabetics discuss rising treatment costs.", "source": "The New York Times", "lead_paragraph": "The drug company Eli Lilly and an organization that helps diabetics discuss rising treatment costs.", "word_count": "470", "pub_date": "2016-02-29T00:00:00Z", "subsection_name": null, "blog": [], "type_of_material": "Letter", "section_name": "Opinion", "web_url": "http://www.nytimes.com/2016/02/29/opinion/for-some-diabetics-a-struggle-to-pay-for-insulin.html", "_id": "56d3ff7638f0d86ef22e18be"}